BackTerns Pharmaceuticals Overview

Terns Pharmaceuticals Selling, General & Admin

Selling, General & Admin expenses for TERN.

Quarterly SG&A Expenses

$8.70M
↑ 9.49% YoY

As of Dec 31, 2025

Annual SG&A Expenses (TTM)

$32.13M
↑ 2.7% YoY

Trailing 12 months ending Dec 31, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin